Oren Barboy
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 9
- CAR-T cell therapy research 6
- Cancer Immunotherapy and Biomarkers 3
-
- Immunotherapy and Immune Responses 3
- T-cell and B-cell Immunology 2
- Co-authors
- Ido Amit (4 shared papers)Amos Tanay (2 shared papers)Eyal David (3 shared papers)Merav Cohen (2 shared papers)Amir Giladi (2 shared papers)Eitan E. Winter (1 shared paper)Matteo Iannacone (1 shared paper)Yuval Shapir Itai (1 shared paper)
- Journals
- Nature Cancer (4 papers)Nature Medicine (2 papers)Cell (2 papers)Cancer Cell (1 paper)Cancer Discovery (1 paper)
- Partner nations
- IsraelUnited StatesNetherlands
In The Last Decade
Oren Barboy
10 papers receiving 637 citations
Oren Barboy's Hit Papers
Peers
Comparison fields: 5 of 61
- Immunology 263
- Oncology 193
- Hepatology 40
- Pathology and Forensic Medicine 67
- Cancer Research 49
Countries citing papers authored by Oren Barboy
This map shows the geographic impact of Oren Barboy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oren Barboy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oren Barboy more than expected).
Fields of papers citing papers by Oren Barboy
This network shows the impact of papers produced by Oren Barboy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oren Barboy. The network helps show where Oren Barboy may publish in the future.
Co-authors
The 25 scholars most cited alongside Oren Barboy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 151 | |
| 2 | 2022 | 146 | |
| 3 | 2022 | 109 | |
| 4 | Bispecific dendritic-T cell engager potentiates anti-tumor immunity Hit paper breakdown → | 2024 | 92 |
| 5 | 2022 | 61 | |
| 6 | 2023 | 42 | |
| 7 | 2024 | 22 | |
| 8 | 2025 | 17 | |
| 9 | 2023 | 8 | |
| 10 | 2026 | 2 | |
| 11 | 2025 | 0 |
About Oren Barboy
Oren Barboy is a scholar working on Oncology, Immunology, Hepatology, Hematology and Pathology and Forensic Medicine, having authored 11 papers that have together received 650 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), T-cell and B-cell Immunology (2 papers), Liver Diseases and Immunity (1 paper), Diabetes and associated disorders (1 paper), Wnt/β-catenin signaling in development and cancer (1 paper) and Connective Tissue Growth Factor Research (1 paper). The work is most often cited by research in Immunology (263 citations), Oncology (193 citations), Hepatology (40 citations), Pathology and Forensic Medicine (67 citations) and Cancer Research (49 citations). Oren Barboy has collaborated with scholars based in Israel, United States and Netherlands. Frequent co-authors include Ido Amit, Amos Tanay, Eyal David, Merav Cohen, Amir Giladi, Eitan E. Winter, Matteo Iannacone, Yuval Shapir Itai, Akhiad Bercovich and Mark Buckup. Their work appears in journals such as Nature Cancer, Nature Medicine, Cell, Cancer Cell and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.